The lung cancer surgery equipment market size has grown strongly in recent years. It will grow from $3.73 billion in 2025 to $3.98 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to limited availability of advanced thoracic surgery equipment, reliance on traditional open surgeries, increasing prevalence of lung cancer, rising number of hospital and surgical clinics, adoption of standard biopsy and imaging procedures.
The lung cancer surgery equipment market size is expected to see strong growth in the next few years. It will grow to $5.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of robotic-assisted and minimally invasive surgical tools, integration of ai-enabled imaging and monitoring systems, growing investment in research and academic institutes, rising adoption of enhanced recovery after surgery (ERAS) protocols, expansion of specialized lung cancer treatment centers. Major trends in the forecast period include increasing adoption of minimally invasive lung surgeries, rising demand for advanced imaging and diagnostic equipment, integration of patient monitoring systems with surgical devices, growing focus on postoperative rehabilitation and aftercare, expansion of robotic-assisted thoracic surgery.
The increasing prevalence of lung cancer is anticipated to drive the growth of the lung cancer surgery equipment market in the coming years. Lung cancer is a condition characterized by the uncontrolled growth of abnormal cells in the lungs, often caused by smoking or exposure to harmful environmental factors. The rise in lung cancer cases is primarily linked to increased exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, along with an aging global population. Lung cancer surgery equipment plays a critical role in diagnosing the disease, removing cancerous tissue, and facilitating post-operative care through accurate surgical procedures and effective patient monitoring. For example, in February 2025, the Cancer Council, an Australia-based non-profit organization, reported that an estimated 15,122 individuals were diagnosed with lung cancer in Australia in 2024, with the average age at diagnosis being 72. Lung cancer is the fifth most commonly diagnosed cancer in the country, and around one in 20 Australians is projected to be diagnosed with it by the age of 85. Hence, the rising prevalence of lung cancer is contributing to the expansion of the lung cancer surgery equipment market.
Leading companies in the lung cancer surgery equipment market are concentrating on the development of robotically assisted bronchoscopy devices to enhance the accuracy and safety of tumor localization and biopsy, facilitate access to difficult-to-reach lung nodules, and support early and precise lung cancer diagnosis. Robotically assisted bronchoscopy is an advanced procedure that employs robotic systems to guide a bronchoscope - a slender, flexible tube - into the lungs with greater accuracy and control compared to conventional manual methods. For instance, in March 2025, Johnson & Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received 510(k) clearance from the U.S. FDA. This system represents the next generation of the MONARCH Platform, developed to enhance lung cancer diagnosis through minimally invasive techniques. The MONARCH QUEST system integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration significantly increases the precision of targeting lung nodules, particularly those located in hard-to-access regions of the lung.
In August 2024, Karl Storz SE & Co. KG, a medical technology company based in Germany, acquired Asensus Surgical Inc. for an undisclosed sum. Through this acquisition, Karl Storz intends to strengthen its position in the surgical robotics sector and broaden its offerings by incorporating Asensus Surgical’s cutting-edge digital and robotic-assisted surgical technologies. Asensus Surgical Inc., headquartered in the United States, is a medical technology firm specializing in the development of surgical robots and digital solutions for a range of procedures, including lung cancer surgery.
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S.
North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lung cancer surgery equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the lung cancer surgery equipment market by increasing costs for imported surgical instruments, imaging systems, and robotic-assisted devices. Segments like electrosurgical devices, advanced imaging equipment, and robotic surgery platforms are most affected, particularly in regions such as North America and Asia-Pacific where imports are high. The resulting cost increase has led to adjustments in procurement strategies and regional supply chains. On the positive side, tariffs have encouraged local manufacturing, technology innovation, and investment in domestic production facilities.
The lung cancer surgery equipment market research report is one of a series of new reports that provides lung cancer surgery equipment market statistics, including lung cancer surgery equipment industry global market size, regional shares, competitors with a lung cancer surgery equipment market share, detailed lung cancer surgery equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer surgery equipment industry. This lung cancer surgery equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lung cancer surgery equipment encompasses specialized medical devices and tools utilized during surgical procedures aimed at diagnosing, treating, and monitoring lung cancer. This category includes surgical instruments, imaging devices, biopsy tools, electrosurgical equipment, access devices, and patient monitoring systems, all designed to aid in tumor removal, reduce complications, and support patient recovery.
The primary categories of lung cancer surgery equipment consist of surgical instruments, access devices, imaging systems, electrosurgical tools, biopsy devices, and patient monitoring equipment. Surgical instruments are precision tools employed by surgeons to cut, clamp, grasp, or suture tissue during procedures. Common surgical approaches for lung cancer include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. These surgeries serve purposes such as diagnosis, treatment, and post-operative care or rehabilitation. The equipment is used across various end users, including hospitals, surgical clinics, ambulatory surgical centers, and research or academic institutions.
The lung cancer surgery equipment market consists of sales of staplers, forceps, retractors, monopolar and bipolar electrosurgical generators, ultrasonic scalpels, and pulmonary needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lung cancer surgery equipment market size is expected to see strong growth in the next few years. It will grow to $5.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of robotic-assisted and minimally invasive surgical tools, integration of ai-enabled imaging and monitoring systems, growing investment in research and academic institutes, rising adoption of enhanced recovery after surgery (ERAS) protocols, expansion of specialized lung cancer treatment centers. Major trends in the forecast period include increasing adoption of minimally invasive lung surgeries, rising demand for advanced imaging and diagnostic equipment, integration of patient monitoring systems with surgical devices, growing focus on postoperative rehabilitation and aftercare, expansion of robotic-assisted thoracic surgery.
The increasing prevalence of lung cancer is anticipated to drive the growth of the lung cancer surgery equipment market in the coming years. Lung cancer is a condition characterized by the uncontrolled growth of abnormal cells in the lungs, often caused by smoking or exposure to harmful environmental factors. The rise in lung cancer cases is primarily linked to increased exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, along with an aging global population. Lung cancer surgery equipment plays a critical role in diagnosing the disease, removing cancerous tissue, and facilitating post-operative care through accurate surgical procedures and effective patient monitoring. For example, in February 2025, the Cancer Council, an Australia-based non-profit organization, reported that an estimated 15,122 individuals were diagnosed with lung cancer in Australia in 2024, with the average age at diagnosis being 72. Lung cancer is the fifth most commonly diagnosed cancer in the country, and around one in 20 Australians is projected to be diagnosed with it by the age of 85. Hence, the rising prevalence of lung cancer is contributing to the expansion of the lung cancer surgery equipment market.
Leading companies in the lung cancer surgery equipment market are concentrating on the development of robotically assisted bronchoscopy devices to enhance the accuracy and safety of tumor localization and biopsy, facilitate access to difficult-to-reach lung nodules, and support early and precise lung cancer diagnosis. Robotically assisted bronchoscopy is an advanced procedure that employs robotic systems to guide a bronchoscope - a slender, flexible tube - into the lungs with greater accuracy and control compared to conventional manual methods. For instance, in March 2025, Johnson & Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received 510(k) clearance from the U.S. FDA. This system represents the next generation of the MONARCH Platform, developed to enhance lung cancer diagnosis through minimally invasive techniques. The MONARCH QUEST system integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration significantly increases the precision of targeting lung nodules, particularly those located in hard-to-access regions of the lung.
In August 2024, Karl Storz SE & Co. KG, a medical technology company based in Germany, acquired Asensus Surgical Inc. for an undisclosed sum. Through this acquisition, Karl Storz intends to strengthen its position in the surgical robotics sector and broaden its offerings by incorporating Asensus Surgical’s cutting-edge digital and robotic-assisted surgical technologies. Asensus Surgical Inc., headquartered in the United States, is a medical technology firm specializing in the development of surgical robots and digital solutions for a range of procedures, including lung cancer surgery.
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S.
North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lung cancer surgery equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the lung cancer surgery equipment market by increasing costs for imported surgical instruments, imaging systems, and robotic-assisted devices. Segments like electrosurgical devices, advanced imaging equipment, and robotic surgery platforms are most affected, particularly in regions such as North America and Asia-Pacific where imports are high. The resulting cost increase has led to adjustments in procurement strategies and regional supply chains. On the positive side, tariffs have encouraged local manufacturing, technology innovation, and investment in domestic production facilities.
The lung cancer surgery equipment market research report is one of a series of new reports that provides lung cancer surgery equipment market statistics, including lung cancer surgery equipment industry global market size, regional shares, competitors with a lung cancer surgery equipment market share, detailed lung cancer surgery equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer surgery equipment industry. This lung cancer surgery equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lung cancer surgery equipment encompasses specialized medical devices and tools utilized during surgical procedures aimed at diagnosing, treating, and monitoring lung cancer. This category includes surgical instruments, imaging devices, biopsy tools, electrosurgical equipment, access devices, and patient monitoring systems, all designed to aid in tumor removal, reduce complications, and support patient recovery.
The primary categories of lung cancer surgery equipment consist of surgical instruments, access devices, imaging systems, electrosurgical tools, biopsy devices, and patient monitoring equipment. Surgical instruments are precision tools employed by surgeons to cut, clamp, grasp, or suture tissue during procedures. Common surgical approaches for lung cancer include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. These surgeries serve purposes such as diagnosis, treatment, and post-operative care or rehabilitation. The equipment is used across various end users, including hospitals, surgical clinics, ambulatory surgical centers, and research or academic institutions.
The lung cancer surgery equipment market consists of sales of staplers, forceps, retractors, monopolar and bipolar electrosurgical generators, ultrasonic scalpels, and pulmonary needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lung Cancer Surgery Equipment Market Characteristics
3. Lung Cancer Surgery Equipment Market Supply Chain Analysis
4. Global Lung Cancer Surgery Equipment Market Trends and Strategies
5. Lung Cancer Surgery Equipment Market Analysis of End Use Industries
7. Global Lung Cancer Surgery Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lung Cancer Surgery Equipment Total Addressable Market (TAM) Analysis for the Market
9. Lung Cancer Surgery Equipment Market Segmentation
10. Lung Cancer Surgery Equipment Market Regional and Country Analysis
11. Asia-Pacific Lung Cancer Surgery Equipment Market
12. China Lung Cancer Surgery Equipment Market
13. India Lung Cancer Surgery Equipment Market
14. Japan Lung Cancer Surgery Equipment Market
15. Australia Lung Cancer Surgery Equipment Market
16. Indonesia Lung Cancer Surgery Equipment Market
17. South Korea Lung Cancer Surgery Equipment Market
18. Taiwan Lung Cancer Surgery Equipment Market
19. South East Asia Lung Cancer Surgery Equipment Market
20. Western Europe Lung Cancer Surgery Equipment Market
21. UK Lung Cancer Surgery Equipment Market
22. Germany Lung Cancer Surgery Equipment Market
23. France Lung Cancer Surgery Equipment Market
24. Italy Lung Cancer Surgery Equipment Market
25. Spain Lung Cancer Surgery Equipment Market
26. Eastern Europe Lung Cancer Surgery Equipment Market
27. Russia Lung Cancer Surgery Equipment Market
28. North America Lung Cancer Surgery Equipment Market
29. USA Lung Cancer Surgery Equipment Market
30. Canada Lung Cancer Surgery Equipment Market
31. South America Lung Cancer Surgery Equipment Market
32. Brazil Lung Cancer Surgery Equipment Market
33. Middle East Lung Cancer Surgery Equipment Market
34. Africa Lung Cancer Surgery Equipment Market
36. Lung Cancer Surgery Equipment Market Competitive Landscape and Company Profiles
37. Lung Cancer Surgery Equipment Market Other Major and Innovative Companies
40. Lung Cancer Surgery Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Lung Cancer Surgery Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lung cancer surgery equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lung cancer surgery equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lung cancer surgery equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Surgical Instruments; Access Devices; Imaging Equipment; Electrosurgical Devices; Biopsy Devices; Patient Monitoring Equipment2) By Surgery Type: Lobectomy Surgery; Pneumonectomy Surgery; Wedge Resection; Video-Assisted Thoracoscopic Surgery (VATS); Robotic-Assisted Surgery
3) By Application: Diagnosis; Treatment; Aftercare And Rehabilitation
4) By End User: Hospitals; Surgical Clinics; Ambulatory Surgical Centers; Research And Academic Institutes
Subsegments:
1) By Surgical Instruments: Scalpels; Forceps; Retractors; Scissors; Sutures2) By Access Devices: Trocars; Catheters; Guidewires; Introducers
3) By Imaging Equipment: CT Scanners; MRI Machines; PET Scanners; X-Ray Systems; Ultrasound Devices
4) By Electrosurgical Devices: Electrosurgical Generators; Electrosurgical Probes; Electrosurgical Electrodes; Smoke Evacuation Systems
5) By Biopsy Devices: Needle Biopsy Devices; Core Biopsy Devices; Vacuum-Assisted Biopsy Devices; Endoscopic Biopsy Devices
6) By Patient Monitoring Equipment: Pulse Oximeters; ECG Monitors; Respiratory Monitors; Blood Pressure Monitors; Temperature Monitors
Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthcare AG; Fujifilm Limited; GE Healthcare Technologies Inc; Boston Scientific Corporation; Olympus Corporation; Intuitive Surgical Inc; Teleflex Incorporated; KARL STORZ GmbH & Co KG; Integra LifeSciences Corporation; Richard Wolf GmbH; Angiodynamics Inc; B Braun Melsungen AG; Sontec Instruments Inc; Novadaq Technologies Inc; Stryker Corporation; CONMED Corporation; Smith & Nephew plc; Ambu A S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lung Cancer Surgery Equipment market report include:- Johnson & Johnson
- Medtronic plc
- Siemens Healthcare AG
- Fujifilm Limited
- GE Healthcare Technologies Inc
- Boston Scientific Corporation
- Olympus Corporation
- Intuitive Surgical Inc
- Teleflex Incorporated
- KARL STORZ GmbH & Co KG
- Integra LifeSciences Corporation
- Richard Wolf GmbH
- Angiodynamics Inc
- B Braun Melsungen AG
- Sontec Instruments Inc
- Novadaq Technologies Inc
- Stryker Corporation
- CONMED Corporation
- Smith & Nephew plc
- Ambu A S
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.98 Billion |
| Forecasted Market Value ( USD | $ 5.1 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
